221 related articles for article (PubMed ID: 38344202)
1. Current and future on definitive concurrent chemoradiotherapy for inoperable locally advanced esophageal squamous cell carcinoma.
Xie R; Cai Q; Chen T; Huang H; Chen C
Front Oncol; 2024; 14():1303068. PubMed ID: 38344202
[TBL] [Abstract][Full Text] [Related]
2. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.
Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176
[TBL] [Abstract][Full Text] [Related]
3. The current status of multimodality treatment for unresectable locally advanced esophageal squamous cell carcinoma.
Hirano H; Boku N
Asia Pac J Clin Oncol; 2018 Aug; 14(4):291-299. PubMed ID: 29873183
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic findings suggestive of a high risk of non-radical cure after definitive chemoradiotherapy for cT1bN0M0 esophageal squamous cell carcinoma.
Fukuhara M; Urabe Y; Oka S; Ishibashi K; Konishi H; Mizuno J; Tanaka H; Tsuboi A; Yamashita K; Hiyama Y; Takigawa H; Kotachi T; Yuge R; Hayashi R; Nishibuchi I; Murakami Y; Nagata Y; Tanaka S
Esophagus; 2023 Jul; 20(3):541-547. PubMed ID: 37027046
[TBL] [Abstract][Full Text] [Related]
5. Definitive chemoradiotherapy versus esophagectomy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma: A retrospective study.
Jo YY; Yu J; Song KJ; Jang JY; Yoo YJ; Kim SB; Park SR; Kim YH; Kim HR; Kim JH
Radiother Oncol; 2021 Sep; 162():112-118. PubMed ID: 34265356
[TBL] [Abstract][Full Text] [Related]
6. Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy.
Okamoto H; Fujishima F; Kamei T; Nakamura Y; Ozawa Y; Miyata G; Nakano T; Katsura K; Abe S; Taniyama Y; Sakurai T; Teshima J; Hikage M; Sasano H; Ohuchi N
BMC Cancer; 2015 Mar; 15():208. PubMed ID: 25880782
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.
Sugawara K; Yagi K; Okumura Y; Nishida M; Aikou S; Yamashita H; Yamashita H; Seto Y
Int J Clin Oncol; 2020 Apr; 25(4):552-560. PubMed ID: 31828451
[TBL] [Abstract][Full Text] [Related]
8. Clinical prognostic factors for locally advanced esophageal squamous carcinoma treated after definitive chemoradiotherapy.
Kim DE; Kim UJ; Choi WY; Kim MY; Kim SH; Kim MJ; Shim HJ; Hwang JE; Bae WK; Chung IJ; Nam TK; Na KJ; Cho SH
Cancer Res Treat; 2013 Dec; 45(4):276-84. PubMed ID: 24454000
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cisplatinum/paclitaxel with cisplatinum/5-fluorouracil as first-line therapy for nonsurgical locally advanced esophageal squamous cell carcinoma patients.
Hu G; Wang Z; Wang Y; Zhang Q; Tang N; Guo J; Liu L; Han X
Drug Des Devel Ther; 2016; 10():2129-36. PubMed ID: 27445460
[TBL] [Abstract][Full Text] [Related]
10. RATIONALE 311: tislelizumab plus concurrent chemoradiotherapy for localized esophageal squamous cell carcinoma.
Yu R; Wang W; Li T; Li J; Zhao K; Wang W; Liang L; Wu H; Ai T; Huang W; Li L; Yu W; Wei C; Wang Y; Shen W; Xiao Z
Future Oncol; 2021 Nov; 17(31):4081-4089. PubMed ID: 34269067
[TBL] [Abstract][Full Text] [Related]
11. A Nutrition-Related Factor-Based Risk Stratification for Exploring the Clinical Benefits in the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: A Retrospective Cohort Study.
Yu Y; Wu H; Qiu J; Ke D; Wu Y; Lin M; Liu T; Zheng Q; Zheng H; Yang J; Wang Z; Li H; Liu L; Yao Q; Li J; Cheng W; Chen X
Front Nutr; 2022; 9():896847. PubMed ID: 35990358
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Combination of Immunotherapy and Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.
Wang R; Liu S; Chen B; Xi M
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291954
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.
Kawakami T; Tsushima T; Omae K; Ogawa H; Shirasu H; Kito Y; Yoshida Y; Hamauchi S; Todaka A; Machida N; Yokota T; Yamazaki K; Fukutomi A; Onozawa Y; Yasui H
BMC Cancer; 2018 May; 18(1):573. PubMed ID: 29776344
[TBL] [Abstract][Full Text] [Related]
14. Survival outcome of esophagectomy and chemoradiotherapy for resectable esophageal squamous cell carcinoma in patients >75 years of age.
Mayanagi S; Inoue M; Tokizawa K; Fushiki K; Tsushima T; Yokota T; Yamazaki K; Yasui H; Tsubosa Y
Thorac Cancer; 2024 Jun; ():. PubMed ID: 38898742
[TBL] [Abstract][Full Text] [Related]
15. Patient selection for salvage surgery after definitive chemoradiotherapy in esophageal squamous cell carcinoma.
Harada H; Yamashita K; Katada C; Ishiyama H; Soeno T; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Hiki N
Langenbecks Arch Surg; 2020 Sep; 405(6):767-776. PubMed ID: 32671456
[TBL] [Abstract][Full Text] [Related]
16. A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapy.
Wang P; Yang M; Wang X; Zhao Z; Li M; Yu J
Ann Transl Med; 2021 Feb; 9(3):233. PubMed ID: 33708860
[TBL] [Abstract][Full Text] [Related]
17. Dysfunction of apoptosis and autophagy correlates with local recurrence in esophageal squamous cell carcinoma after definitive chemoradiation.
Qiu H; Song H; Luo M; Ke S; Shi W; Chen J; Zhao W; Luo H; Chen Y
Cancer Cell Int; 2021 Sep; 21(1):466. PubMed ID: 34488754
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy combined with immune checkpoint inhibitors in locally advanced/metastatic esophageal squamous cell carcinoma: clinical trials, efficacy and future directions.
Jiang M; Hu Y; Lin G; Chen C; Li H
Front Immunol; 2023; 14():1177085. PubMed ID: 37325652
[TBL] [Abstract][Full Text] [Related]
19. Endostatin and Oxaliplatin-Based Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Results of a Phase II Study.
Li W; Chen P; Zhang N; Song T; Wu S
Oncologist; 2019 Apr; 24(4):461-e136. PubMed ID: 30850562
[TBL] [Abstract][Full Text] [Related]
20. Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial.
Chen Y; Ye J; Zhu Z; Zhao W; Zhou J; Wu C; Tang H; Fan M; Li L; Lin Q; Xia Y; Li Y; Li J; Jia H; Lu S; Zhang Z; Zhao K
J Clin Oncol; 2019 Jul; 37(20):1695-1703. PubMed ID: 30920880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]